Stock 600518 KANGMEI PHARMACEUTICAL CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Company Kangmei Pharmaceutical Co., Ltd.

Equities

600518

CNE0000017M1

Pharmaceuticals

End-of-day quote Shanghai S.E.
Other stock markets
 06:00:00 2024-04-29 pm EDT 		5-day change 1st Jan Change
1.99 CNY -1.97% Intraday chart for Kangmei Pharmaceutical Co., Ltd. +4.74% +6.99%
12:10pm Kangmei Pharmaceutical Logs Profit in Q1 MT
Apr. 29 Kangmei Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI

Business Summary

Kangmei Pharmaceutical Co., Ltd. develops, produces, and sells pharmaceutical products intended primarily for treating hypertension and colds. The group offers Chinese medications (ginseng, salvia, codonopsis, etc.) and chemical medications (clarithromycin, doxazosin mesylate, paracetamol, etc.).

All sales are earned in China.

Number of employees: 4,409

Sales per Business

CNY in Million2022Weight2023Weight Delta
Chinese Medicine
47.8 %
1,906 45.6 % 2,332 47.8 % +22.33%
Western Medicine
29.6 %
1,415 33.9 % 1,441 29.6 % +1.85%
Health Food and Food
10.3 %
325 7.8 % 503 10.3 % +54.90%
Property Rental and Sale and Others
9.2 %
403 9.6 % 448 9.2 % +11.06%
Medical Instruments
2.1 %
112 2.7 % 103 2.1 % -8.14%
Other Business
1.0 %
19 0.5 % 47 1.0 % +149.66%

Sales per region

CNY in Million2022Weight2023Weight Delta
China
100.0 %
4,180 100.0 % 4,874 100.0 % +16.60%

Managers

Managers TitleAgeSince
Guo Wei Liu CEO
 Chief Executive Officer 51 20-10-09
Gui Bo Gong DFI
 Director of Finance/CFO 50 20-10-09
Min Li IRC
 Investor Relations Contact 35 18-12-31
Yun Feng Zhou SEC
 Corporate Secretary 43 20-10-13

Members of the board

Members of the board TitleAgeSince
Xiao Ping Lai BRD
 Director/Board Member 63 20-10-29
Yan Zhu Gao CHM
 Chairman 59 20-10-29
Qi Mi BRD
 Director/Board Member 62 22-01-24
Guo Wei Liu CEO
 Chief Executive Officer 51 20-10-09
Gui Bo Gong DFI
 Director of Finance/CFO 50 20-10-09
Miao Shuang Fang BRD
 Director/Board Member 47 22-01-24
Jun Liang BRD
 Director/Board Member 40 22-01-24
Long Tao Huang BRD
 Director/Board Member 42 22-01-24
Tong Wang BRD
 Director/Board Member 54 22-01-24
Qing Zeng BRD
 Director/Board Member 60 22-01-24

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 13,939,793,690 9,424,440,954 ( 67.61 %) 75,927,000 ( 0.5447 %) 67.61 %

Shareholders

NameEquities%Valuation
Guangzhou State-Owned Assets Supervision & Admin. Commission
25.78 %
3,509,413,788 25.78 % 1 054 M ¥
Xing Tian Ma
4.115 %
560,219,782 4.115 % 168 M ¥
KANGMEI PHARMACEUTICAL CO., LTD.
3.039 %
413,734,278 3.039 % 124 M ¥
Minmetals International Trust Co.,Ltd.
1.704 %
231,901,482 1.704 % 70 M ¥
Guangdong Finance Trust Co., Ltd.
1.336 %
181,818,181 1.336 % 55 M ¥
Shenzhen Qianhai Chongming Wanfang Equity Investment Ltd.
1.202 %
163,612,565 1.202 % 49 M ¥
Chang'An International Trust Co., Ltd.
1.087 %
148,000,000 1.087 % 44 M ¥
Da Cheng Fund Management Co., Ltd.
0.1746 %
23,761,928 0.1746 % 7 M ¥
China Asset Management Co., Ltd.
0.0719 %
9,784,424 0.0719 % 3 M ¥
China Southern Asset Management Co., Ltd.
0.0305 %
4,146,216 0.0305 % 1 M ¥
NameEquities%Valuation
Xing Tian Ma
74.21 %
186,229,400 74.21 % 56 M ¥
Kangmei Pharmaceutical Co. Ltd. ESOP
2.608 %
6,544,502 2.608 % 2 M ¥
Zhong Wei Han
0.0877 %
220,000 0.0877 % 66 053 ¥
Xi Wei Qiu
0.0877 %
220,000 0.0877 % 66 053 ¥
Guo Xiong Lin
0.0877 %
220,000 0.0877 % 66 053 ¥
Yi Qing Zhuang
0.0558 %
140,000 0.0558 % 42 034 ¥

Holdings

NameEquities%Valuation
KANGMEI PHARMACEUTICAL CO., LTD.
3.04%
 413,734,278 3.04% 124,219,580 $

Company contact information

Kangmei Pharmaceutical Co., Ltd.

Xiameilin Taike Road Futian District

518000, Shenzhen

+86 755 3318 7777

http://www.kangmei.com.cn
address Kangmei Pharmaceutical Co., Ltd.(600518)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sales per Business

Annual profits - Rate of surprise

Company calendar

Sector Other Pharmaceuticals

1st Jan change Capi.
KANGMEI PHARMACEUTICAL CO., LTD. Stock Kangmei Pharmaceutical Co., Ltd.
+9.14% 3.89B
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+26.47% 664B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+30.44% 567B
JOHNSON & JOHNSON Stock Johnson & Johnson
-6.33% 354B
MERCK & CO., INC. Stock Merck & Co., Inc.
+19.35% 330B
ABBVIE INC. Stock AbbVie Inc.
+4.23% 286B
ASTRAZENECA PLC Stock AstraZeneca PLC
+14.53% 234B
NOVARTIS AG Stock Novartis AG
+5.15% 199B
ROCHE HOLDING AG Stock Roche Holding AG
-10.02% 196B
AMGEN INC. Stock Amgen Inc.
-4.04% 148B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 600518 Stock
  4. Company Kangmei Pharmaceutical Co., Ltd.